De novo biosynthesis of 2'-fucosyllactose by bioengineered Corynebacterium glutamicum.
Ye-Gi LeeHae-Yong JoDo-Haeng LeeJong-Won YoonYoung-Ha SongDae-Hyuk KweonKyoung Heon KimYong-Cheol ParkJin-Ho SeoPublished in: Biotechnology journal (2023)
2'-Fucosyllactose (2'-FL) which is well-known human milk oligosaccharide was biotechnologically synthesized using engineered Corynebacterium glutamicum, a GRAS microbial workhorse. By construction of the complete de novo pathway for GDP-L-fucose supply and heterologous expression of Escherichia coli lactose permease and Helicobacter pylori α-1,2-fucosyltransferase, bioengineered C. glutamicum BCGW_TL successfully biosynthesized 0.25 g/L 2'-FL from glucose. The additional genetic perturbations including the expression of a putative 2'-FL exporter and disruption of the chromosomal pfkA gene allowed C. glutamicum BCGW_cTTLEΔP to produce 2.5 g/L 2'-FL batchwise. Finally, optimized fed-batch cultivation of the BCGW_cTTLEΔP using glucose, fructose, and lactose resulted in 21.5 g/L 2'-FL production with a productivity of 0.12 g/L•h, which were more than 3.3 times higher value relative to the batch culture of the BCGW_TL. Conclusively, it would be a groundwork to adopt C. glutamicum for biotechnological production of other food additives including human milk oligosaccharides. This article is protected by copyright. All rights reserved.
Keyphrases
- human milk
- helicobacter pylori
- low birth weight
- poor prognosis
- escherichia coli
- copy number
- preterm infants
- helicobacter pylori infection
- genome wide
- blood glucose
- microbial community
- preterm birth
- long non coding rna
- dna methylation
- adipose tissue
- gene expression
- metabolic syndrome
- biofilm formation
- risk assessment
- human health